Stifel Reiterates Buy Rating on Kymera Therapeutics (KYMR)

Go back to Stifel Reiterates Buy Rating on Kymera Therapeutics (KYMR)
(NASDAQ: KYMR) Delayed: 117.39 +2.97 (2.60%)
Previous Close $114.42    52 Week High
Open $112.90    52 Week Low
Day High $118.04    P/E N/A 
Day Low $110.05    EPS
Volume 468,580